Japan gov't panel approves 2 iPS-derived drugs

Japan gov't panel approves 2 iPS-derived drugs

University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.

  • Product Code
  • ILEA005070594
  • Registered date
  • 2026/2/19 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2026 Kyodo News
  • Media size
  • 3350 × 2233 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 692.06(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan gov't panel approves 2 iPS-derived drugs

    Japan gov't panel approves 2 iPS-derived drugs

    University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
      Japan gov't panel approves 2 iPS-derived drugs

      Japan gov't panel approves 2 iPS-derived drugs

      University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.
        World's 1st transplant of iPS heart muscle tissue

        World's 1st transplant of iPS heart muscle tissue

        Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
          World's 1st transplant of iPS heart muscle tissue

          World's 1st transplant of iPS heart muscle tissue

          Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
            World's 1st transplant of iPS heart muscle tissue

            World's 1st transplant of iPS heart muscle tissue

            Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
              World's 1st transplant of iPS heart muscle tissue

              World's 1st transplant of iPS heart muscle tissue

              Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                World's 1st transplant of iPS heart muscle tissue

                World's 1st transplant of iPS heart muscle tissue

                Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                  World's 1st transplant of iPS heart muscle tissue

                  World's 1st transplant of iPS heart muscle tissue

                  Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo
                    iPS-derived cells become part of rat's heart tissue, doctor says

                    iPS-derived cells become part of rat's heart tissue, doctor says

                    Osaka University professor Yoshiki Sawa, a cardiovascular surgeon, reports at a press conference in Osaka, western Japan, on Jan. 25, 2015, that a cardiac muscle sheet of induced pluripotent stem (iPS) cells has assimilated with the heart tissue of a rat. (Kyodo) ==Kyodo
                      World's 1st transplant surgery using iPS cells conducted

                      World's 1st transplant surgery using iPS cells conducted

                      KYOTO, Japan - Kyoto University professor Shinya Yamanaka holds a press conference in Kyoto on Sept. 12, 2014, after a Japanese research team transplanted retinal cells grown from induced pluripotent stem cells to a woman in her 70s earlier in the day, marking the first time iPS-derived cells have been introduced into a human body by surgery. Yamanaka developed iPS cells, a type of stem cells that can grow into various human body tissue.